Taken together, these data show that in the majority of cancer cell lines, upregulated or unchanged CD73 expression occurs after effective inhibition of the MAPK‐RAS pathway, while in the remaining cancer cell lines, the CD73 levels decreased. Here, NT5E is linked to cancer.